[Research in clinical epidemiology: which rules should be applied?]

Area of Science:

• Biomedical research law
• Healthcare policy
• Clinical trial regulation

Context:

• The 2007 French healthcare research regulations were implemented following the adaptation of European directive 2001/20/CE.
• Key innovations include retaining distinctions between biomedical research, research on standard care, and non-interventional research.
• These legislative changes have increased the complexity of the research framework.

Purpose:

• To review and present the application of the 2007 French healthcare research regulations.
• To guide researchers by outlining four critical questions to consider before initiating research.
• To highlight areas where regulatory simplification has been partially achieved but further clarification is needed.

Summary:

• The article details a four-question framework to assess research compliance under the 2007 French regulations: (1) specific procedures on individuals, (2) use of human biological material, (3) processing of personal patient data, and (4) inclusion of genetic data.
• The regulations aim for procedural simplification but have introduced new complexities.
• Unanswered questions persist, particularly concerning epidemiological research.

Impact:

• Provides a practical guide for researchers navigating French biomedical research legislation.
• Identifies persistent regulatory complexities, especially in epidemiology, suggesting areas for future legislative refinement.
• Contributes to understanding the practical implications of harmonizing European directives with national research frameworks.